Jaebum Choo, professor in the Department of Bionano Technology at the Hanyang University, to give a presentation titled "Application of SERS-based optofluidic sensor for highly sensitive biomedical diagnosis," at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.
Paul W. Bohn, Arthur J Schmitt Professor of Chemical & Biomolecular Engineering, University of Notre Dame, to give a presentation titled "Tight Coupling of Chemical Sensing and Reactivity in Nanofluidic Architectures" at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.
Sunney Xie, Mallinckrodt Professor of Chemistry, Department of Chemistry and Chemical Biology at Harvard University, to give keynote presentation titled, "Life at the Single Molecule Level: Single Cell Genomics," at the Inaugural Single Cell Analysis Conference to be held in Cambridge, MA on May 22-23, 2014 by GTC.
Susan Cheng, Associate Physician and Instructor in Medicine at Brigham and Women's Hospital, will Speak at the Metabolomics Conference - Advances & Applications in Human Disease on May 22-23, 2014 in Cambridge, MA.
Charles Wang, Director for the Center for Genomics, and Professor of Microbiology and Molecular Genetics at Loma Linda University to give a presentation titled "Single-Cell Transcriptome Analysis of Mouse Cardiomyocytes Derived Progenitor Cells," at the Inaugural Single Cell Analysis in Cambridge, MA on May 22-23, 2014 by GTC.
Ken Livak, Senior Scientific Fellow at Fluidigm will give a featured presentation titled, "Driving Genomics to the Single-Cell Level: RNA Expression Profiling Using qPCR and RNAseq," at the Inaugural Single Cell Analysis Conference to be held in Cambridge, MA on May 22-23, 2014 by GTC.
The Association of Biotechnology Led Enterprises (ABLE), the apex body of the biotech sector in India has successfully concluded its flagship annual conference 'BIOINVEST 2014' in Mumbai today with prominent industry experts debating and discussing on the need for investment in biotechnology sector.
The province of Santa Fe in Argentina will be leading the biggest-ever foreign government delegation to BioAsia at this year's edition. The 40-member delegation comprising ministers, senators, bureaucrats, industry and institutions from Santa Fe will be present at BioAsia 2014 to be held from February 17 to 19, 2014 at the Hyderabad International Convention Centre (HICC), Hyderabad.
The Platinum Capital Group in Hong Kong today announced the appointment of Mr. Larrs Mueller as it's new Retail Accounts Director. The appointment is officially effective from December 31st, 2013, when he will also join the Board.
The Platinum Capital Group, the Hong Kong based boutique Investment Firm in the Private Equity market, today confirmed the firm's attendence at the 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Lisbon next year.
AdvantaPure now offers its APSPG silicone pump tubing in .313" I.D. x .500" O.D. to help meet customer demand. The tubing, which is USP Class VI approved, is stocked in ten other sizes as well. APSPG is specially formulated to withstand the rigors of peristaltic pump operations and offers other benefits such as no animal-derived ingredients, translucency and documented lot traceability.
Gyorgi Keri, Professor, CEO & CSO at Vichem Chemie Research Ltd. will give a presentation titled "Developing Kinase Inhibitors for Personalized Therapy," at the Protein Kinases in Drug Discovery Conference - Europe in Berlin, Germany on May 8-9, 2014 by GTC.
Ahead of the 9th SmartLab Exchange (25-26 of February, Munich), industry leaders took part in a series of interviews surrounding the key trends that will impact the laboratory informatics industry in 2014.
Frank Sasinowski will speak about orphan drugs approved under the FDA's Subpart H at the second annual Orphan Drugs Research & Commercialization Conference, to be held February 20-21, 2014 in San Diego, CA.
Bob Butchofsky, President and CEO of Mati Therapeutics to Present at the 6th Ocular Diseases & Drug Discovery Conference.(March 20-21, 2014 in San Diego, CA)
Scott R. Pancoast, President and Chief Executive Officer of Lpath to Present at the 6th Ocular Diseases & Drug Discovery Conference on March 20-21, 2014 in San Diego, CA.
Sir Philip Cohen, Co-Director of the Division of Signal Transduction Therapy and Professor of Enzymology at Dundee University will give the keynote presentation at the Protein Kinases in Drug Discovery Conference to be held in Berlin, Germany on May 8-9, 2014 by GTC.
Allen D. Roses, President of Barbaresco Pharmaceuticals To Give a Plenary Keynote Presentation on "A post-GWAS Method for Translating Statistical Associations to Disease-relevant Pathways" at the Biomarker Summit 2014.
Gabriel Vargas, Executive Medical Director of Neuroscience Early Development at Amgen to Give a Featured Presentation on "Advances in Translational Neuroscience" at the 3rd Neurological Biomarkers Conference.
Mahmoud Loughman-Adham, Global Medical Director at Baxter BioScience to Give a Presentation on "The Use of Biomarkers to Accelerate Clinical Development of Drugs for Kidney Diseases" at the 3rd Inflammatory & Immunological Biomarkers Conference.
Scott Patterson, Executive Director of Medical Sciences at Amgen To Give a Featured Presentation on "Continued Exploration of Tumor Molecular Characteristics Further Improves Patient Outcomes" at the 7th Oncology Biomarkers Conference.
Stephen Groft, Director of the Office of Rare Diseases at the NIH, to Give Keynote Presentation at the Orphan Drugs Research & Commercialization Conference, February 20-21, 2014 in San Diego, CA. Dr. Groft and other stakeholders in the community will gather and share complementary perspectives on topics such as gene therapy, natural history studies, regulatory challenges, and much more.
Francisco Leon, Vice President, Translational Medicine, Immunology Development at Janssen R&D To Give a Plenary Keynote Presentation at the 6th Immunotherapeutics & Immunomonitoring Conference.
Leroy Hood, President of the Institute for Systems Biology, To Give a Keynote Presentation on "Systems Approaches to Disease: Emerging Technologies and Novel Strategies including Blood Diagnostics" at the Biomarker Summit 2014.(March 19-21, 2014 in San Diego, CA)
Peter Openshaw, Director at the National Heart and Lung Institute, Imperial College, UK, Professor of Experimental Medicine, and Honorary Physician at the St Mary's Campus of the Imperial College NHS Trust, will give a presentation at the Inaugural Innate Immunity Conference, January 29-31, 2014 in San Diego, CA.
Satisfied Users & 
Approved Press Releases
